Cargando…
p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling
BACKGROUND: Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths primarily due to chemoresistance. Somatic mutation of TP53 (36%) and epidermal growth factor receptor (EGFR; > 30%) are major contributors to cisplatin (CDDP) resistance. Substantial evidence suggests the elevate...
Autores principales: | Zhang, Yize, Han, Chae Young, Duan, Fu Gang, Fan, Xing-Xing, Yao, Xiao-Jun, Parks, Robin J., Tang, Yi-Jun, Wang, Mei-Fang, Liu, Liang, Tsang, Benjamin K., Leung, Elaine Lai-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642601/ https://www.ncbi.nlm.nih.gov/pubmed/31360122 http://dx.doi.org/10.1186/s12935-019-0910-2 |
Ejemplares similares
-
SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
por: She, Kelin, et al.
Publicado: (2019) -
Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration
por: Duan, Hongying, et al.
Publicado: (2014) -
[6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling
por: Jiang, Xueyi, et al.
Publicado: (2021) -
miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway
por: Cao, Qinxue, et al.
Publicado: (2020) -
Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway
por: Wu, Zhaojia, et al.
Publicado: (2019)